During this cooking tutorial, this woman tries to show how to cook chestnuts. She forgets that overheated chestnuts are vulnerable to explosion, and the chestnut winds up exploding. BBC leaders resign ...

Footage from Kentucky State Police Trooper Jude Remilien's body-worn camera shows the moments leading up to a serious shooting, and the moments afterward where good Samaritans come to his aid. New ...

WOBURN, Mass., Oct. 19, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today ...

Kentucky State Police say that Oliver was located off Crooked Creek Road in the Reed community and arrested on Wednesday morning at around 10 a.m. He was reportedly taken into custody without incident ...

WOBURN, Mass., Oct. 20, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced ...

After rejecting Replimune’s melanoma drug RP1 this summer, the FDA has accepted the biotech’s resubmission of an approval application. The federal agency said it expects to reach a decision on or ...

Replimune Group announced that the U.S. Food and Drug Administration has accepted the resubmission of its Biologics License Application for RP1 in combination with nivolumab, targeting advanced ...

Replimune received FDA acceptance for its RP1 BLA resubmission in advanced melanoma, with a PDUFA date set for April 2026. REPL stock surged nearly 100% on the news, but FDA acceptance only restarts ...

Prescription Drug User Fee Act (PDUFA) target action date set for April 10, 2026 WOBURN, Mass., Oct. 20, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology ...

Shares of Replimune Group, Inc. (NASDAQ:REPL) are rising Monday after the clinical stage biotechnology company shared an important regulatory update. What To Know: Replimune said the U.S. Food and ...

The biotech received the good news it was hoping for from a top national regulator. This concerned RP1, its advanced melanoma drug. Well before market open, Replimune announced that the U.S. Food and ...